Crossmark

Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication

Crossref DOI link: https://doi.org/10.1016/j.oftale.2016.11.003

Published Print: 2017-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Costales-Álvarez, C.

Álvarez-Coronado, M.

Rozas-Reyes, P.

González-Rodríguez, C.M.

Fernández-Vega, L.
License Information

Text and Data Mining valid from 2017-02-01
More Information

This article is maintained by: Elsevier

Article Title: Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2016.11.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2016.07.002

Content Type: article

Copyright: © 2016 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.